UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Durvalumab and multiple sclerosis: a causal link or simple unmasking?

European journal of clinical pharmacology, 2020-12, Vol.76 (12), p.1773-1774

2020

Volltextzugriff (PDF)

The role of exercise parameters on small extracellular vesicles and microRNAs cargo in preventing neurodegenerative diseases

Frontiers in physiology, 2023-08, Vol.14, p.1241010-1241010

2023

Volltextzugriff (PDF)

Long-term disability trajectories in relapsing multiple sclerosis patients treated with early intensive or escalation treatment strategies

Therapeutic advances in neurological disorders, 2021, Vol.14, p.17562864211019574-17562864211019574

2021

Volltextzugriff (PDF)

Cladribine effects on patient-reported outcomes and their clinical and biometric correlates in highly active relapsing multiple sclerosis at first switch: the observational, multicenter, prospective, phase IV CLADFIT-MS study

Frontiers in neurology, 2024-07, Vol.15, p.1422078

2024

Volltextzugriff (PDF)

A nurse-led, telephone-based patient support program for improving adherence in patients with relapsing-remitting multiple sclerosis using interferon beta-1a: Lessons from a consumer-based survey on adveva® PSP

Frontiers in psychology, 2022-08, Vol.13, p.965229-965229

2022

Volltextzugriff (PDF)

Mitochondria, Oxidative Stress, cAMP Signalling and Apoptosis: A Crossroads in Lymphocytes of Multiple Sclerosis, a Possible Role of Nutraceutics

Antioxidants, 2021-01, Vol.10 (1), p.21

2021

Volltextzugriff (PDF)

Cerebrospinal fluid neurofilament light levels mark grey matter volume in clinically isolated syndrome suggestive of multiple sclerosis

Multiple sclerosis, 2018-07, Vol.24 (8), p.1039-1045

2018

Volltextzugriff (PDF)

Lymphocyte Count and Body Mass Index as Biomarkers of Early Treatment Response in a Multiple Sclerosis Dimethyl Fumarate-Treated Cohort

Frontiers in immunology, 2019-06, Vol.10, p.1343-1343

2019

Volltextzugriff (PDF)

A case report of late‐onset atypical Hemolytic Uremic Syndrome during interferon beta in multiple sclerosis: Open issues in literature review

Brain and behavior, 2021-01, Vol.11 (1), p.e01930-n/a

2021

Volltextzugriff (PDF)

Longitudinal Evaluation of Serum MOG-IgG and AQP4-IgG Antibodies in NMOSD by a Semiquantitative Ratiometric Method

Frontiers in neurology, 2021-03, Vol.12, p.633115-633115

2021

Volltextzugriff (PDF)

PBMC of Multiple Sclerosis Patients Show Deregulation of OPA1 Processing Associated with Increased ROS and PHB2 Protein Levels

Biomedicines, 2020-04, Vol.8 (4), p.85

2020

Volltextzugriff (PDF)

Acoustic Voice Analysis as a Useful Tool to Discriminate Different ALS Phenotypes

Biomedicines, 2023-08, Vol.11 (9), p.2439

2023

Volltextzugriff (PDF)

Real-Life Experience of the Effects of Cladribine Tablets on Lymphocyte Subsets and Serum Neurofilament Light Chain Levels in Relapsing Multiple Sclerosis Patients

Brain sciences, 2022-11, Vol.12 (12), p.1595

2022

Volltextzugriff (PDF)

Magnetoencephalography and High-Density Electroencephalography Study of Acoustic Event Related Potentials in Early Stage of Multiple Sclerosis: A Pilot Study on Cognitive Impairment and Fatigue

Brain sciences, 2021-04, Vol.11 (4), p.481

2021

Volltextzugriff (PDF)

Effect of Cladribine on Neuronal Apoptosis: New Insight of In Vitro Study in Multiple Sclerosis Therapy

Brain sciences, 2020-08, Vol.10 (8), p.548

2020

Volltextzugriff (PDF)

An Internet- and Kinect-Based Multiple Sclerosis Fitness Intervention Training With Pilates Exercises: Development and Usability Study

JMIR serious games, 2023-01, Vol.11, p.e41371-e41371

2023

Volltextzugriff (PDF)

The Value and Sustainability of Ocrelizumab in Relapsing Multiple Sclerosis: A Cost-Effectiveness and Budget Impact Analysis

Farmeconomia. Health economics and therapeutic pathways, 2019-07, Vol.20 (1)

2019

Volltextzugriff (PDF)

Review of interferon beta-1b in the treatment of early and relapsing multiple sclerosis

Biologics, 2009-01, Vol.3 (default), p.369-376

2009

Volltextzugriff (PDF)

Siponimod from fingolimod direct switch in patients transitioning in secondary progressive multiple sclerosis: A single center case series

Clinical neurology and neurosurgery, 2024-10, Vol.245, p.108475, Article 108475

2024

Volltextzugriff (PDF)

Efficacy and Safety of Oral Therapies for Relapsing-Remitting Multiple Sclerosis

CNS drugs, 2020, Vol.34 (1), p.65-92

2020

Volltextzugriff (PDF)

Early considerations about the safety of cenobamate in the treatment of status epilepticus

Neurological sciences, 2024-07

2024

Volltextzugriff (PDF)

Interdisciplinary approach to opportunistic infections: staphylococcal meningitis in a patient with multiple sclerosis on treatment with dimethyl fumarate

Internal and emergency medicine, 2022-09, Vol.17 (6), p.1845-1847

2022

Volltextzugriff (PDF)

Effectiveness and safety of ocrelizumab in a real-world setting: A single center experience from southern italy

Journal of the neurological sciences, 2021-10, Vol.429, p.117790, Article 117790

2021

Volltextzugriff (PDF)

1 – 25 von 51

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

KollektionOxford Journals Current Collection

ThemaNeuroradiology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(39)

Publikationsform

Artikel
(49)
Berichte
(2)

Sprache

Englisch
(51)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Durvalumab and multiple sclerosis: a causal link or simple unmasking?

The role of exercise parameters on small extracellular vesicles and microRNAs cargo in preventing neurodegenerative diseases

Long-term disability trajectories in relapsing multiple sclerosis patients treated with early intensive or escalation treatment strategies

Cladribine effects on patient-reported outcomes and their clinical and biometric correlates in highly active relapsing multiple sclerosis at first switch: the observational, multicenter, prospective, phase IV CLADFIT-MS study

Transition to secondary progression in relapsing-onset multiple sclerosis: Definitions and risk factors

A nurse-led, telephone-based patient support program for improving adherence in patients with relapsing-remitting multiple sclerosis using interferon beta-1a: Lessons from a consumer-based survey on adveva® PSP

Mitochondria, Oxidative Stress, cAMP Signalling and Apoptosis: A Crossroads in Lymphocytes of Multiple Sclerosis, a Possible Role of Nutraceutics

Cerebrospinal fluid neurofilament light levels mark grey matter volume in clinically isolated syndrome suggestive of multiple sclerosis

Lymphocyte Count and Body Mass Index as Biomarkers of Early Treatment Response in a Multiple Sclerosis Dimethyl Fumarate-Treated Cohort

A case report of late‐onset atypical Hemolytic Uremic Syndrome during interferon beta in multiple sclerosis: Open issues in literature review

Longitudinal Evaluation of Serum MOG-IgG and AQP4-IgG Antibodies in NMOSD by a Semiquantitative Ratiometric Method

PBMC of Multiple Sclerosis Patients Show Deregulation of OPA1 Processing Associated with Increased ROS and PHB2 Protein Levels

Acoustic Voice Analysis as a Useful Tool to Discriminate Different ALS Phenotypes

Real-Life Experience of the Effects of Cladribine Tablets on Lymphocyte Subsets and Serum Neurofilament Light Chain Levels in Relapsing Multiple Sclerosis Patients

Predicted Expenditure for Prescription Drugs for Multiple Sclerosis in the Italian Market Between 2023 and 2028: Results of the Oracle Project

Magnetoencephalography and High-Density Electroencephalography Study of Acoustic Event Related Potentials in Early Stage of Multiple Sclerosis: A Pilot Study on Cognitive Impairment and Fatigue

Effect of Cladribine on Neuronal Apoptosis: New Insight of In Vitro Study in Multiple Sclerosis Therapy

An Internet- and Kinect-Based Multiple Sclerosis Fitness Intervention Training With Pilates Exercises: Development and Usability Study

The Value and Sustainability of Ocrelizumab in Relapsing Multiple Sclerosis: A Cost-Effectiveness and Budget Impact Analysis

Review of interferon beta-1b in the treatment of early and relapsing multiple sclerosis

Siponimod from fingolimod direct switch in patients transitioning in secondary progressive multiple sclerosis: A single center case series

Efficacy and Safety of Oral Therapies for Relapsing-Remitting Multiple Sclerosis

Early considerations about the safety of cenobamate in the treatment of status epilepticus

Interdisciplinary approach to opportunistic infections: staphylococcal meningitis in a patient with multiple sclerosis on treatment with dimethyl fumarate

Effectiveness and safety of ocrelizumab in a real-world setting: A single center experience from southern italy

Aktive Filter

Suchergebnisse filtern